Related Experiment Video
Updated: Jan 23, 2026
11:44
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
11.5K
Humanized Mouse Models for the Study of Hepatitis C and Host Interactions
Kylie Su Mei Yong1, Zhisheng Her2, Qingfeng Chen3,4,5
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Proteos, Singapore 138673, Singapore. yongsmk@imcb.a-star.edu.sg.
Cells
|June 20, 2019
Summary
Humanized mice, which contain human liver and immune cells, are crucial for studying Hepatitis C virus (HCV) infection and developing new treatments. These models advance understanding of HCV-mammalian host interactions and therapeutic strategies.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis C virus (HCV) causes chronic liver diseases like cirrhosis and cancer.
- HCV's narrow host tropism (humans and primates) limits in vivo research.
- Developing effective therapeutics and vaccines is hindered by current research models.
Purpose of the Study:
- To discuss the utility of humanized mice in Hepatitis C virus (HCV) research.
- To define humanized mice as models with human hepatocytes or both liver and immune cells.
- To explore the application of these models in understanding HCV immunopathogenesis and treatment.
Main Methods:
- Focus on humanized mouse models in HCV research.
- Define humanized mice based on human cell engraftment (hepatocytes or liver/immune cells).
- Review literature on immunopathogenesis, antiviral interventions, and drug testing using these models.
Main Results:
- Humanized mice provide a viable in vivo system for studying HCV.
- These models allow investigation of HCV-mammalian host interactions.
- Humanized mice facilitate evaluation of antiviral drugs and vaccine efficacy.
Conclusions:
- Humanized mice are indispensable tools for advancing HCV research.
- These models offer new perspectives for developing HCV therapeutics and vaccines.
- Further research utilizing humanized mice will enhance understanding and control of HCV infection.
Keywords:
cirrhosishepatitis C virushepatocellular carcinomahepatotropic diseasehumanized miceliversteatosisMore Related Videos
Related Concept Videos
02:43Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
281
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
281
02:39Predator-Prey Interactions
21.2K
Predators consume prey for energy. Predators that acquire prey and prey that avoid predation both increase their chances of survival and reproduction (i.e., fitness). Routine predator-prey interactions elicit mutual adaptations that improve predator offenses, such as claws, teeth, and speed, as well as prey defenses, including crypsis, aposematism, and mimicry. Thus, predator-prey interactions resemble an evolutionary arms race.
21.2K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219